OPTN (OptiNose Inc) Market Valuation

OptiNose, Inc. (OPTN) generates revenue from the sale of ENT therapy products, with the drug XHANCE serving as the primary profit generator. The business relies on partnerships with specialized physicians to implement advanced drug delivery methods for the sinuses. Market price visualization on the GURU.Markets platform shows a capitalization of 0.10. A stable team of developers and growing sales of nasal sprays support the company's human capital potential.

OPTN OptiNose: Market Capitalization in the range 07/04/2022 - 05/31/2025

Comprehensive metric breakdowns and analytics for OptiNose Corp (OPTN)

- market price and analyst price targets:

Price Chart OptiNose|OPTN - Forecast Levels Chart

- business market valuation indicators:

Market Valuation OptiNose Corp|OPTN - Aggregate Business Value

- business book valuation details:

Net Assets per Single Share OptiNose|OPTN - Accounting Capitalization|Market Value to Book Value Ratio optinose.com|OPTN - Total Asset Value of Company

- debt obligations and liquidity statistics:

- business earnings and investment ratios data:

OPTN - Net Profit|Future Profit OptiNose, Inc.|OPTN - Company Value to Net Income|Future Price to Earnings Optinose|OPTN - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio OptiNose Corp|OPTN - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) OptiNose|OPTN - Earnings per share for the trailing year|Quarterly EPS earnings growth optinose.com|OPTN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year OptiNose, Inc.

Fundamental company analysis:OPTN (OptiNose)

OptiNose, Inc. (OPTN) drug development is subject to regulatory risks and geopolitical restrictions on raw materials. The current value of all the issuer's shares aggregates these factors, recalculating the business's market weight daily. This metric measures total market capitalization, reflecting investors' real-time assessment of the company's fundamental stability. Real-time calculation allows for the detection of sharp capital shifts faster than quarterly reports. By analyzing the total market capitalization of OptiNose, Inc. (OPTN), one can identify abnormal price spikes.

Key competitors